How Effective Is The Prostate Biopsy?
Of the one million prostate biopsies carried out each year in the United States alone as many as one quarter produce negative results, in spite of the fact that those concerned do in fact have prostate cancer. As a result, it is important that we find a way to identify those men for whom a follow-up biopsy is required.
Every year there are about one million prostate biopsies carried out in the United States alone, of which about 25 percent show the presence of prostate cancer. However, another 25 percent of these biopsies also produce false negative results, which means that a quarter of those men undergoing a prostate biopsy are being cleared by their biopsy, despite the fact that they do in fact have prostate cancer.
These results do not means that there is anything wrong with the prostate biopsy procedure as a tool for identifying prostate cancer, but it does mean that there is a need to identify those patients who, despite returning a negative result, are at high risk from prostate cancer and should therefore undergo a second follow-up biopsy.
Until now there has been no simple way of identifying patients at risk, however, a recent study of more than 500 patients being investigated for prostate cancer may provide a solution.
All of the men in the study group had previously received a negative biopsy result and researchers found that when they looked at both a patient's prostate specific antigen (PSA) test results and adjusted this for the size of the prostate gland they were able to identify those patients who were more likely to receive a positive result on a follow-up biopsy.
The researchers also discovered that a Gleeson score of 7 or higher suggested the presence of a life-threatening prostate cancer and the need for a further biopsy. The Gleeson score, which runs on a scale between 2 and 10, is derived from a microscopic investigation of biopsy tissue, with a low score indicating a cancer with a low risk of spread and a high score indicating a cancer which is more likely to spread.
A prostate biopsy is an expensive procedure and one which can also be very worrying for the patient. It can also be a painful procedure which can be accompanied by bleeding and patients run the risk of infection following the biopsy. For these reasons it is in everyone's interest to identify those patients for whom a second biopsy is advisable and to reduce as far as possible the number of unnecessary follow-up biopsies being performed each year.
ProstateCancerExplained.com provides information on a wide range of topics including the prostate gland, an enlarged prostate, prostatitis, prostate surgery and finding a prostate cancer cure.
These results do not means that there is anything wrong with the prostate biopsy procedure as a tool for identifying prostate cancer, but it does mean that there is a need to identify those patients who, despite returning a negative result, are at high risk from prostate cancer and should therefore undergo a second follow-up biopsy.
Until now there has been no simple way of identifying patients at risk, however, a recent study of more than 500 patients being investigated for prostate cancer may provide a solution.
All of the men in the study group had previously received a negative biopsy result and researchers found that when they looked at both a patient's prostate specific antigen (PSA) test results and adjusted this for the size of the prostate gland they were able to identify those patients who were more likely to receive a positive result on a follow-up biopsy.
The researchers also discovered that a Gleeson score of 7 or higher suggested the presence of a life-threatening prostate cancer and the need for a further biopsy. The Gleeson score, which runs on a scale between 2 and 10, is derived from a microscopic investigation of biopsy tissue, with a low score indicating a cancer with a low risk of spread and a high score indicating a cancer which is more likely to spread.
A prostate biopsy is an expensive procedure and one which can also be very worrying for the patient. It can also be a painful procedure which can be accompanied by bleeding and patients run the risk of infection following the biopsy. For these reasons it is in everyone's interest to identify those patients for whom a second biopsy is advisable and to reduce as far as possible the number of unnecessary follow-up biopsies being performed each year.
ProstateCancerExplained.com provides information on a wide range of topics including the prostate gland, an enlarged prostate, prostatitis, prostate surgery and finding a prostate cancer cure.

Use the feedback form below to submit your comments.

Use the form below to email this article to your friends.

- PSA Tests Supply A Very Good Indication Of The Presence of An Aggressive Prostate Cancer
- Prostate Massage - Milking the Prostate Gland
- Prostrate Problems: Symptoms, Diagnosis and Treatment
- Preventative Medicine And The Use Of Prostate Massage
- Prostatitis
- Prostate Exam
- BPH Affects More Than Half Of All Men Above The Age Of 60
- Over-The-Counter Prostate Medication Can Be Downright Dangerous
- 7 Prostate Symptoms Which You Should Watch For
- Prostate Problem Symptoms - The Signs To Look For
- Cardura - Treatment for Benign Prostatic Hyperplasia (BPH)
- Everything You Need To Know About Prostate Problems
- Prostate Problems Men Need to be Aware of
- Prostate Herbs - A Natural Prostate Cure
- Veterans Warned of Possible Exposure to Viruses
- Prostate Problems in Young Men
- Function of Prostate Gland
- Prostate Infection Symptoms
- Causes of Prostate Infection
- Prostate Problems Symptoms
- Benign Prostatic Hyperplasia :Symptoms and Treatment



